Is Centene (CNC) Undervalued Following Strong Q3 Results And Raised Guidance?

Centene (CNC) just put fresh numbers on the table, with Q3 2026 results and updated guidance that point to higher full year revenue expectations and a new floor for GAAP diluted EPS.

Centene’s share price has climbed 63.83% year to date, with a 30 day share price return of 8.67% and a 90 day gain of 7.36%, pointing to building momentum around the turnaround narrative following the strong Q3 release and raised guidance.

Spot opportunities riding similar healthcare momentum by scanning our hand-picked 34 healthcare AI stocks that combine earnings stories with clear operational execution.

After a near 64% run this year and a sharp reset in earnings expectations, Centene’s turnaround story is now embedded in the price. Does the current valuation still leave enough upside to justify taking on new risk?

Most Popular Narrative: 7% Undervalued

Centene closed at $68.45 against a most-followed fair value estimate of $73.50. This frames the current debate around how much of the turnaround is already reflected and how much of the margin recovery story is still being priced in by the market.

Centene's effort to restore Medicaid margins, supported by a 2026 composite rate yield outlook of roughly 5% and a targeted full year Medicaid HBR of about 93.5%, continues to point to earnings power that some investors may not yet fully reflect in valuation, with potential impact on segment net margins.

See why 60 investors see Centene as 7% undervalued.

Result: Fair Value of $73.50 (UNDERVALUED)

Still, policy shifts that reduce support for Medicaid or Marketplace members, along with slower than expected Medicaid margin recovery, could quickly challenge the Centene turnaround narrative.

Find out about the key risks to this Centene narrative.

Next Steps

Mixed feelings about Centene's momentum and valuation are clear, so treat this as a starting point and pressure test the data yourself quickly before sentiment shifts. To balance both the optimism and the caution, take a closer look at the 4 key rewards and 2 important warning signs.

Looking for more Centene sized investment ideas?

If Centene has sharpened your focus, do not stop here. Broaden your watchlist now, because the next opportunity will not wait for you.

• Target stronger downside protection by reviewing companies in the 29 resilient stocks with low risk scores that aim to pair resilience with measured return potential.
• Chase better value by scanning the 33 high quality undervalued stocks where solid balance sheets and earnings profiles may not yet be fully reflected in prices.
• Spot potential early movers by checking the 19 high quality undiscovered gems that combine quality fundamentals with limited current market attention.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com